Patents by Inventor Shifeng Pan

Shifeng Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS
    Publication number: 20080139559
    Abstract: Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 12, 2008
    Applicants: IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY, NOVARTIS
    Inventors: Valentina Molteni, Shuli You, Juliet Nabakka, Yi Liu, Xiaolin Li, Donatella Chianelli, Jon Loren, Xiaodong Liu, Shifeng Pan, Donald S. Karanewsky, Pascal Furet, Vito Guagnano
  • DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS
    Publication number: 20080139597
    Abstract: Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 12, 2008
    Applicants: IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY, NOVARTIS, AG
    Inventors: Valentina Molteni, Xiaolin Li, Donatella Chianelli, Jon Loren, Juliet Nabakka, Xiaodong Liu, Shifeng Pan, Yi Liu, Donald S. Karanewsky, Pascal Furet, Vito Guagnano, Shuli You
  • LANTANA PLANT NAMED 'BANTE ROSSA'
    Publication number: 20070245434
    Abstract: A lantana plant particularly distinguished by large purple-pink and yellow flowers, a continuous, abundant and mid-season flowering response, medium green foliage with ovate leaves, vigorous growth, a medium to tall, spreading and mounding plant habit, and good branching ability, is disclosed.
    Type: Application
    Filed: April 18, 2006
    Publication date: October 18, 2007
    Inventor: Shifeng Pan
  • LANTANA PLANT NAMED 'BANTE CHERIA'
    Publication number: 20070245435
    Abstract: A lantana plant particularly distinguished by mainly red to cherry-red and partly yellow to orange flowers, a continuous, abundant and mid-season flowering response, deep green foliage with ovate leaves, medium vigor, a compact and mounding plant habit and a well-branched and tight plant habit, is disclosed.
    Type: Application
    Filed: April 18, 2006
    Publication date: October 18, 2007
    Inventor: Shifeng Pan
  • Immunosuppressant Compounds and Compositions
    Publication number: 20070203100
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Application
    Filed: February 24, 2005
    Publication date: August 30, 2007
    Applicant: IRM LLC
    Inventors: Shifeng Pan, Thomas Marsilje, Wenshuo Lu, Gao Wenqi, Nathanael Gray, Yun He, Yahua Liu, Yuan Mi, Yongping Xie
  • Bicyclic compounds and compositions
    Patent number: 7256206
    Abstract: The present invention relates to bicyclic derivatives, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG/S1P receptor mediated signal transduction.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: August 14, 2007
    Assignee: IRM LLC
    Inventors: Shifeng Pan, Nathanael S. Gray, Yuan Mi, Wenqi Gao, Yi Fan, Sophie Lefebvre
  • Immunosuppressant compounds and compositions
    Publication number: 20070167410
    Abstract: The present invention relates to immunosuppressants, processes for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Application
    Filed: February 24, 2005
    Publication date: July 19, 2007
    Applicant: IRM LLC
    Inventors: Shifeng Pan, Wenqi Gao, Nathanael Gray, Yuan Mi
  • Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors
    Publication number: 20070149538
    Abstract: Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.
    Type: Application
    Filed: September 26, 2006
    Publication date: June 28, 2007
    Applicants: IRM LLC, Novartis, AG
    Inventors: Valentina Molteni, Xiaolin Li, Donatella Chianelli, Jon Loren, Shuli You, Juliet Nabakka, Xiadong Liu, Shifeng Pan, Yi Liu, Donald Karanewsky, Pascal Furet, Vito Guagnano
  • Bis-aromatic alkanols
    Patent number: 7169817
    Abstract: The present invention relates to biphenylyl derivatives, processes for their production, their uses and pharmaceutical compositions containing them. Compounds according to the present invention are based upon the chemical formula: wherein the substituents have the values mentioned herein.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: January 30, 2007
    Assignee: IRM LLC
    Inventors: Shifeng Pan, Nathanael S. Gray, Wenqui Gao, Klaus Hinterding, Sophie Lefebvre, Yuan Mi, Peter Nussbaumer, Wei Wang, Federic Zecri, Fan Yi, Lawrence Blas Perez, Kenneth Richad la Montagne, Peter Ettmayer
  • Immunosuppressant compounds and compositions
    Patent number: 7060697
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: June 13, 2006
    Assignee: IRM LLC
    Inventors: Thomas H. Marsilje, Nathanael S. Gray, Tao Jiang, Wenshuo Lu, Shifeng Pan
  • Solution phase sythesis of arylbenzoxazoles
    Patent number: 6861533
    Abstract: This invention provides methods for the solution-phase synthesis of arylbenzoxazoles. The methods involve condensation of aminophenols with benzaldehydes to form a Schiff base. The Schiff base is then induced to undergo oxidative cyclization in the presence of DDQ. The resulting arylbenzoxazoles can be separated from the reduced DDQ byproduct by treatment of reaction mixture with a strongly basic ion exchange resin.
    Type: Grant
    Filed: November 19, 2002
    Date of Patent: March 1, 2005
    Assignee: IRM LLC
    Inventors: Junbiao Chang, Shifeng Pan
  • Immunosuppressant compounds and compositions
    Publication number: 20050014725
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 20, 2005
    Applicant: IRM LLC
    Inventors: Yuan Mi, Shifeng Pan, Nathanael Gray, Wenqi Gao, Yi Fan, Tao Jiang
  • Immunosuppressant compounds and compositions
    Publication number: 20050014724
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 20, 2005
    Applicant: IRM LLC, a Delaware Limited Liability Company
    Inventors: Thomas Marsilje, Nathanel Gray, Tao Jiang, Wenshuo Lu, Shifeng Pan
  • Immunosuppressant compounds and compositions
    Publication number: 20050014728
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 20, 2005
    Inventors: Shifeng Pan, Wenqi Gao, Nathanael Gray, Yuan Mi, Yi Fan
  • Immunosuppressant compounds and compositions
    Publication number: 20050009786
    Abstract: The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
    Type: Application
    Filed: May 19, 2004
    Publication date: January 13, 2005
    Applicant: IRM LLC, a Delaware Limited Liability Company
    Inventors: Shifeng Pan, Nathanael Gray, Yuan Mi, Yi Fan, Wengi Gao
  • Novel bicyclic compounds and compositions
    Publication number: 20040248952
    Abstract: The present invention relates to bicyclic derivatives, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG/S1P receptor mediated signal transduction.
    Type: Application
    Filed: February 11, 2004
    Publication date: December 9, 2004
    Applicant: IRM LLC, a Delaware Limited Liability Company
    Inventors: Shifeng Pan, Nathanael S. Gray, Yuan Mi, Wenqi Gao, Yi Fan, Sophie Lefebvre
  • Bis-aromatic alkanols
    Publication number: 20040048857
    Abstract: The present invention relates to biphenylyl derivatives, processes for their production, their uses and pharmaceutical compositions containing them.
    Type: Application
    Filed: May 27, 2003
    Publication date: March 11, 2004
    Applicants: IRM LLC, Novartis AG
    Inventors: Shifeng Pan, Nathanael S. Gray, Wenqi Gao, Klaus Hinterding, Sophie Lefebvre, Yuan Mi, Peter Nussbaumer, Wei Wang, Federic Zecri, Fan Yi, Lawrence Blas Perez, Kenneth Richard la Montagne, Peter Ettmayer
  • Solution phase synthesis of arylbenzoxazoles
    Publication number: 20030148387
    Abstract: This invention provides methods for the solution-phase synthesis of arylbenzoxazoles. The methods involve condensation of aminophenols with benzaldehydes to form a Schiff base. The Schiff base is then induced to undergo oxidative cyclization in the presence of DDQ. The resulting arylbenzoxazoles can be separated from the reduced DDQ byproduct by treatment of reaction mixture with a strongly basic ion exchange resin.
    Type: Application
    Filed: November 19, 2002
    Publication date: August 7, 2003
    Applicant: IRM LLC, a Delaware LLC
    Inventors: Junbiao Chang, Shifeng Pan
  • Lantana plant named ‘Bante Cheria’
    Patent number: PP18115
    Abstract: A lantana plant particularly distinguished by mainly red to cherry-red and partly yellow to orange flowers, a continuous, abundant and mid-season flowering response, deep green foliage with ovate leaves, medium vigor, a compact and mounding plant habit and a well-branched and tight plant habit, is disclosed.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: October 9, 2007
    Assignee: Goldsmith Seeds, Inc.
    Inventor: Shifeng Pan
  • Lantana plant named ‘Bante Rossa’
    Patent number: PP18148
    Abstract: A lantana plant particularly distinguished by large purple-pink and yellow flowers, a continuous, abundant and mid-season flowering response, medium green foliage with ovate leaves, vigorous growth, a medium to tall, spreading and mounding plant habit, and good branching ability, is disclosed.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: October 30, 2007
    Assignee: Goldsmith Seeds, Inc.
    Inventor: Shifeng Pan